ClinicalTrials.Veeva

Menu

A Longitudinal Study in 1st Degree Relatives of Parkinson's Disease (PD) Patients

T

Tel Aviv Sourasky Medical Center

Status

Unknown

Conditions

Parkinson's Disease

Treatments

Other: neurological examination

Study type

Observational

Funder types

Other

Identifiers

NCT01502384
TASMC-11-NG-0463

Details and patient eligibility

About

This is a longitudinal study in healthy 1st degree relatives of patients with Parkinson's Disease (PD) carriers of a genetic mutation in genes that are known to increase the risk for PD. The purpose of this study is to explore the association between genetic mutations in the known genes and early preclinical symptoms such as motor, sensory, autonomic, behavioral and cognitive functions.

Enrollment

100 estimated patients

Sex

All

Ages

35 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy 1ST degree relatives of PD patients with known genotype that participated in an earlier genetic study at the sourasky medical center.

Exclusion criteria

  • subjects with cognitive decline by the parameters defined in DSM- IV
  • subjects with psychiatric disorder
  • subjects unable to sign a consent form

Trial design

100 participants in 1 patient group

healthy relatives
Description:
healthy 1st degree relatives of PD patients
Treatment:
Other: neurological examination

Trial contacts and locations

1

Loading...

Central trial contact

Anat Mirelman, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems